Ken Griffin Avid Bioservices, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$6.7 - $12.45 $40,200 - $74,700	6,000 Added 28.17%	27,300 $310,000
Q2 2024 Aug 14, 2024	SELL	$6.34 - $9.28 $185,128 - $270,976	-29,200 Reduced 57.82%	21,300 $152,000
Q1 2024 May 15, 2024	BUY	$5.86 - $8.79 $204,514 - $306,770	34,900 Added 223.72%	50,500 $338,000
Q4 2023 Feb 14, 2024	BUY	$4.64 - $9.56 $45,008 - $92,732	9,700 Added 164.41%	15,600 $101,000
Q3 2023 Nov 14, 2023	BUY	$9.4 - $14.04 $940 - $1,404	100 Added 1.72%	5,900 $55,000
Q2 2023 Aug 14, 2023	SELL	$12.96 - $20.93 $11,664 - $18,837	-900 Reduced 13.43%	5,800 $81,000
Q1 2023 May 15, 2023	SELL	$13.48 - $18.79 $12,132 - $16,911	-900 Reduced 11.84%	6,700 $125,000
Q4 2022 Feb 14, 2023	SELL	$12.61 - $18.74 $102,141 - $151,794	-8,100 Reduced 51.59%	7,600 $104,000
Q3 2022 Nov 14, 2022	BUY	$15.33 - $20.36 $85,848 - $114,016	5,600 Added 55.45%	15,700 $300,000

183

67.8M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $760M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.